Entering text into the input field will update the search result below

Nutanix downgraded to Underweight at Morgan Stanley, reiterated Buy at Needham and Company amid 21% post-earnings decline [updated]

Mar. 03, 2017 9:37 AM ETNutanix, Inc. (NTNX) StockNTNXBy: Eric McCaffrey, SA News Editor8 Comments
  • Reducing target from $29 to $20 and rating from Equal Weight (Bloomberg-sourced), analyst Katy Huberty (Morgan Stanley) projects near-term Nutanix trade closer to firm's modified base case (vs. midpoint between base case and bull case) given market crowding (HPE/SimpliVity, Cisco HyperFlex cited) and removed possibility for new, sizable OEM partners, commodity-generated margin pressure, decelerating OEM growth, less large deals, greater Y/Y DSOs, shifts in U.S. sales force and forthcoming (March 28) lock-up expiry of approximately 84M shares.
  • Analyst Richard Kugele (Needham & Company), unmoved on rating and target ($36), considers issues impacting outlook immaterial longer-term. Further spotlights company's reiteration of plan to reach sustained free cash flow by year-end CY 2017.
  • Nutanix (NASDAQ:NTNX) $24.66.
  • Yesterday (March 2, 2017): Nutanix -15%; Q2 2017 over consensus, outlook off / earnings call transcript

Recommended For You

About NTNX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NTNX--
Nutanix, Inc.